Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed No phase listed Observational

Outcomes Following Severe Distal Tibia, Ankle and/or Foot Trauma: Comparison of Limb Salvage Versus Transtibial Amputation Protocol

ClinicalTrials.gov ID: NCT01606501

Public ClinicalTrials.gov record NCT01606501. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 3:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Outcomes Following Severe Distal Tibia, Ankle and/or Foot Trauma: Comparison of Limb Salvage Versus Transtibial Amputation Protocol (OUTLET Study)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary aim this prospective longitudinal observational outcomes study is to compare 18 month functional outcomes and health related quality of life (HRQoL) of patients undergoing salvage versus amputation following severe distal tibia, ankle and/or foot fractures with major soft tissue, bone and/or ankle articular surface loss. Functional outcomes and HRQoL will be measured using well established self reported measures, including the Veterans Rand Health Survey (VR-12) and the Short Musculoskeletal Functional Assessment (SMFA). Hypothesis 1: As a group, salvage patients with severe distal tibia, ankle and/or foot injuries with major soft tissue, bone and/or ankle articular surface loss will have similar functional outcomes and HRQoL had they undergone a transtibial amputation (within 6 weeks of injury). Hypothesis 2: The subgroup of salvage patients who have either (1) a soft tissue injury that requires tissue transfer; (2) articular damage requiring arthrodesis of the ankle joint; or (3) bone loss at the distal tibia or ankle will have better functional outcomes and HRQoL had they undergone a transtibial amputation (within 6 weeks of injury).

Study identification

NCT ID
NCT01606501
Recruitment status
Completed
Study type
Observational
Phase
Not listed
Enrollment
664 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2012
Primary completion
Sep 19, 2019
Completion
Sep 19, 2019
Last update posted
Mar 23, 2021

2012 – 2019

United States locations

U.S. sites
33
U.S. states
22
U.S. cities
29
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Navy Medical Center San Diego San Diego California 92134
University of California San Francisco Medical Center San Francisco California 94143
Denver Health and Hospital Authority Denver Colorado 80204
Walter Reed National Military Medical Center Washington D.C. District of Columbia 20307
University of Miami Ryder Trauma Center Miami Florida 33136
Orlando Regional Medical Center Orlando Florida 32806
Florida Orthopaedic Institute, St. Joseph's Hospital Tampa Florida 33606
Florida Orthopaedic Institute, Tampa General Hospital Tampa Florida 33606
Eskenazi Health Indianapolis Indiana 46202
OrthoIndy Methodist Hospital Indianapolis Indiana 46202
St. Vincent Indianapolis Hospital Indianapolis Indiana 46260
University of Iowa Medical Center Iowa City Iowa 52242
University of Maryland Medical Center Baltimore Maryland 21201
Orthopaedic Associates of Michigan Grand Rapids Michigan 49525
Hennepin County Medical Center Minneapolis Minnesota 55430
University of Mississippi Medical Center Jackson Mississippi 39216
Barnes Jewish Hospital St Louis Missouri 63110
St. Louis University Medical Center St Louis Missouri 63110
Jamaica Hospital Medical Center Jamaica New York 11418
Carolinas Medical Center Charlotte North Carolina 28203
Duke University Medical Center Durham North Carolina 27710
Wake Forest Baptist Medical Center Winston-Salem North Carolina 27103
MetroHealth Cleveland Ohio 44109
Oklahoma University Medical Center Oklahoma City Oklahoma 73104
Penn State Hershey Medical Center Hershey Pennsylvania 17033
University of Pittsburgh Medical Center Pittsburgh Pennsylvania 15213
Rhode Island/ Brown University Providence Rhode Island 02905
Vanderbilt Medical Center Nashville Tennessee 37232
University of Texas Health Science Center at Houston Houston Texas 77030
San Antonio Military Medical Center San Antonio Texas 78434
University of Virginia Charlottesville Virginia 22908
University of Washington/Harborview Medical Center Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01606501, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 23, 2021 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01606501 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →